Who owns ANBIO BIOTECHNOLOGY?
- Ticker: NNNN
- CUSIP Number: g0367b105
Tip: Access positions for across all investors
Analyze quarterly positions in Anbio Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anbio Biotechnology stock
Who bought or sold ANBIO BIOTECHNOLOGY this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 26k | $662k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 10k | $267k | 940% | Mar 2026 |
|
| Morgan Stanley | 7.3k | $189k | 26107% | Mar 2026 |
|
| UBS Group | 6.3k | $163k | 122% | Mar 2026 |
|
| EverSource Wealth Advisors | 266.00 | $6.8k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 100.00 | $2.6k | 0% | Mar 2026 |
|
| Ronald Blue Trust | 5.00 | $128.000000 | 100% | Mar 2026 |
|
Who sold out of Anbio Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Sep 2025 | 10k | $389k |
| XTX Topco | Sep 2025 | 6.9k | $257k |